Wilske B, Luft B, Schubach W H, Zumstein G, Jauris S, Preac-Mursic V, Kramer M D
Max von Pettenkofer Institut für Hygiene und Medizinische Mikrobiologie, Universität München, Federal Republic of Germany.
Med Microbiol Immunol. 1992;181(4):191-207. doi: 10.1007/BF00215765.
The outer surface protein A (OspA) of Borrelia burgdorferi is a major candidate for development of a borrelia vaccine. However, vaccine development may be aggravated by the immunological heterogeneity of OspA. In this respect the knowledge about conserved and variable epitopes is of major interest. In this study truncated proteins derived from two different OspA serotypes of B. burgdorferi were mapped for conserved and specific antibody-binding domains. The OspA fragments were reacted in the Western blot with eight different OspA-specific monoclonal antibodies recognizing between one and seven of the seven OspA serotypes previously described. The two broadly reacting antibodies (recognizing all serotypes) react with N-terminal fragments of 93 and 214 amino acids, respectively, whereas antibodies recognizing only one and two to four of the seven serotypes are reactive with C-terminal fragments of amino acid 143-273 and 109-273, respectively. Thus, conserved antibody-binding domains are located nearer to the N terminus than serotype-specific ones. Comparison of the results from western blot mapping with OspA sequence data suggested certain conserved or variable regions as probable candidates for antigenic sites involved in linear or conformationally dependent epitopes. This, however, needs to be confirmed by epitope mapping using the respective synthetic peptides.
伯氏疏螺旋体的外表面蛋白A(OspA)是开发疏螺旋体疫苗的主要候选对象。然而,OspA的免疫异质性可能会加剧疫苗的研发难度。在这方面,关于保守和可变表位的知识备受关注。在本研究中,对源自伯氏疏螺旋体两种不同OspA血清型的截短蛋白进行了保守和特异性抗体结合域的定位。OspA片段在蛋白质印迹中与8种不同的OspA特异性单克隆抗体反应,这些抗体可识别之前描述的7种OspA血清型中的1至7种。两种广泛反应的抗体(识别所有血清型)分别与93和214个氨基酸的N端片段反应,而仅识别7种血清型中的1种以及2至4种的抗体分别与143 - 273和109 - 273氨基酸的C端片段反应。因此,保守的抗体结合域比血清型特异性的结合域更靠近N端。蛋白质印迹定位结果与OspA序列数据的比较表明,某些保守或可变区域可能是参与线性或构象依赖性表位的抗原位点的候选区域。然而,这需要通过使用相应的合成肽进行表位定位来证实。